Ulm, M.A.; Redfern, T.M.; Wilson, B.R.; Ponnusamy, S.; Asemota, S.; Blackburn, P.W.; Wang, Y.; ElNaggar, A.C.; Narayanan, R.
Integrin-Linked Kinase Is a Novel Therapeutic Target in Ovarian Cancer. J. Pers. Med. 2020, 10, 246.
https://doi.org/10.3390/jpm10040246
AMA Style
Ulm MA, Redfern TM, Wilson BR, Ponnusamy S, Asemota S, Blackburn PW, Wang Y, ElNaggar AC, Narayanan R.
Integrin-Linked Kinase Is a Novel Therapeutic Target in Ovarian Cancer. Journal of Personalized Medicine. 2020; 10(4):246.
https://doi.org/10.3390/jpm10040246
Chicago/Turabian Style
Ulm, Michael A., Tiffany M. Redfern, Ben R. Wilson, Suriyan Ponnusamy, Sarah Asemota, Patrick W. Blackburn, Yinan Wang, Adam C. ElNaggar, and Ramesh Narayanan.
2020. "Integrin-Linked Kinase Is a Novel Therapeutic Target in Ovarian Cancer" Journal of Personalized Medicine 10, no. 4: 246.
https://doi.org/10.3390/jpm10040246
APA Style
Ulm, M. A., Redfern, T. M., Wilson, B. R., Ponnusamy, S., Asemota, S., Blackburn, P. W., Wang, Y., ElNaggar, A. C., & Narayanan, R.
(2020). Integrin-Linked Kinase Is a Novel Therapeutic Target in Ovarian Cancer. Journal of Personalized Medicine, 10(4), 246.
https://doi.org/10.3390/jpm10040246